Skip to content
healthcare.dev

COLESEVELAM

NDC 70771-1368, COLESEVELAM, tablet, from Zydus Lifesciences Limited.

Product NDC
70771-1368
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207765
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1368 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • COLESEVELAM HYDROCHLORIDE625 mg/1

Pharmacologic classes

Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]

Package NDCNDC-11Package
70771-1368-0707711368001000 TABLET in 1 BOTTLE (70771-1368-0)
70771-1368-47077113680410 BLISTER PACK in 1 CARTON (70771-1368-4) / 10 TABLET in 1 BLISTER PACK (70771-1368-2)
70771-1368-870771136808180 TABLET in 1 BOTTLE (70771-1368-8)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/090eabd5-acd3-43ed-a05b-52f1f3773a93

Use it

Look up 70771-1368 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1368 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1368. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.